A case report: a heterozygous deletion (2791_2805 del) in exon 18 of the filamin C gene causing filamin C-related myofibrillar myopathies in a Chinese family

Filamin C-related myofibrillar myopathies (MFM) caused by mutations in the filamin C gene (FLNC) are autosomal dominant inherited and characterized by progressive myopathies that eventually result in wheelchair dependence. The FLNC gene is located in the 7q32-q35 chromosome band and includes 48 coding exons. To date, a continually increasing number of mutations in the FLNC gene have been reported in various populations worldwide. Among these mutations, codon 2710 is a mutational hotspot [1]. Mutations in different functional domains of filamins can cause various clinical phenotypes [2, 3]. Most patients with mutations in FLNC-Ig-like domains 7, 22, and 24 present with weakness in limb-girdle muscles, cardiomyopathy, and typical protein aggregation [1, 2, 4, 5], while those with mutations in the actin-binding domains or Ig-like domain 15 mostly present with weakness in the distal muscles and no cardiomyopathy or typical pathology [6, 7]. Here, we report a Chinese family suffering from filamin-C-related MFM caused by a novel 15-bp deletion in exon 18 of the FLNC gene.

A 43-year-old woman suffered progressively worsening proximal muscle weakness for 10 years resulting in difficulties with fast walking, climbing stairs, and rising from a chair. She had experienced normal growth and development. She reported lumbar back pain. Now, the symptom of proximal lower limb weakness had spread to her arms, causing her difficulty in washing clothes. Her father, sister, brother, three paternal aunts, one paternal uncle, and the uncle’s son also had slowly progressive proximal muscle weakness, but not as severe as hers. The pedigree of her family revealed an autosomal dominant inheritance pattern (Fig. 1). Muscle weakness was detected in the biceps and triceps muscles (MRC4+/5), wrist flexor extensor muscles (MRC 4/5), iliopsoas muscles (MRC 3/5), and quadriceps muscles (MRC 4−/5). Her distal arm strength was 4. She had a waddling gait and muscle atrophy in the quadriceps and distal lower legs. In her most recent examination, she could not walk on her toes. Deep tendon reflexes were absent. Gower’s sign was present. No cranial nerve dysfunction or sensory disturbance was noted. Her serum level of creatine kinase was 2-fold higher than the upper normal value. An electromyogram revealed mild myogenic changes. Echocardiography and electrocardiogram evaluations did not detect any cardiac abnormalities. Fatty degeneration was detected in a few lower limb muscles by magnetic resonance imaging (MRI), including the vastus intermedius, vastus lateralis, semimembranosus, adductor magnus and the long head of the biceps femoris muscles. The rectus femoris was slightly involved. No abnormalities were detected in the gracilis, sartorius, or semitendinosus muscles. At the distal leg level, the soleus, gastrocnemius medialis, and gastrocnemius lateralis showed degeneration with fatty infiltration (Fig. 2). After the patient provided written consent, a skeletal muscle biopsy was taken from the tibial anterior muscle, precooled with isopentane, and frozen in liquid nitrogen. Frozen sections of 8 μm were prepared and histopathological examination showed increased fiber size variability with atrophic and hypertrophic fibers. Muscle fiber necrosis and phagocytosis were observed. There was a mild increase in connective tissue. Non-rimmed vacuoles were commonly present. Some fibers showed structural changes with abnormal material deposits after staining with hematoxylin-eosin (HE), modified Gomori’s trichrome (MGT) (Fig. 3a and b). Oxidative enzyme activities were reduced focally in some fibers, occasionally resulting in core-like lesions after staining with succinate dehydrogenase (SDH), NADH-tetrazolium reductase (NADH-TR), and cytochrome c oxidase (COX) (Fig. 3c and d). Electron microscopy showed myofibrillar deposits of thin filaments interspersed with dense granular material between myofibrils, frequently in spheroid shape. These structures were surrounded by radially arranged thin filaments (Fig. 4). Next generation sequencing identified a 15-nucleotide deletion (c.2791_2805del, p.931_935del) in the immunoglobulin (Ig)-like domain 7 of the FLNC gene (Fig. 5). Genetic testing revealed that this deletion had been passed to the patient from her father and carried by her other symptomatic relatives. The patient and her relatives were administered 10 mg per day coenzyme Q10 and some vitamins for about 1 year, but their symptoms were not relieved.

In the current case, a novel 15-bp deletion in the FLNC gene showed an autosomal dominant inheritance pattern and caused muscle weakness in all limbs, a mildly elevated serum level of creatine kinase, slight myogenic changes on EMG, variations in muscle fiber size, and the presence of abnormal protein aggregates and vacuoles in some muscle fibers. These phenotypic manifestations were also observed in the previously identified FLNC gene mutation-mediated MFM cases [1, 2, 4, 5].

The FLNC gene is located in the 7q32-q35 chromosome band and contains 48 coding exons. In general, three different domains harbored in the filamin-C protein may have different filaminS C-related myopathy phenotypes: N-terminal acting-binding domain and the frameshift deletion c.5161delG mutation in the rod domain involved with distal muscle weakness [6, 8], 24 Ig-like repeat domains, and a C-terminal dimerization domain associated with limb-girdle proximal muscle weakness [1]. In 2016, a 15-bp (c.2786_2800del) mutation in the Ig-like domain 7 of the FLNC gene was reported to cause limb-girdle muscular dystrophy (LGMD) [9], whereas the novel 15-bp (c.2791_2805del) mutation in the same domain in our case obviously caused the clinical phenotypes of filamin C–related MFM and displayed a typical autosomal dominant inheritance pattern. The two deletions in the same domain are very likely to result in protein aggregation in muscle fibers, causing similar clinical phenotypes [4, 5, 10]. The variation in fiber size and the presence of necrosis and fatty degeneration in muscle tissues in our case, which were also observed in cases harboring different mutations in the same Ig-like domain [4, 5], indicate that mutations in the Ig-like domain 7 of the FLNC gene lead to structural changes in skeletal muscles. The presence of phagocytosis, non-rimmed vacuoles, and abnormal material deposits in the muscles in our case, which is in agreement with the observations in other Ig-like domain 7 mutation-mediated filamin C–related MFM cases [4, 5] and in cultured cells transfected with expression vectors for the FLNC gene with a mutation in Ig-like domain 7 [10], indicates that the 15-bp deletion in the Ig-like domain 7 of the FLNC gene in our case may lead to protein misfolding, trigger aggregation of the mutant filamin C protein, and decrease the efficiency of both the ubiquitin–proteasome system and autophagy system to degrade protein aggregates [10‐13]. These events ultimately result in disruption of myofibrils [10, 14] and muscle weakness.

In conclusion, a novel 15-nucleotide deletion (c.2791_2805del, p.931_935del) in the Ig-like domain 7 of the FLNC gene was found to cause filamin C–related MFM. This deletion in the FLNC gene causes protein aggregation, abnormalities in muscle structure, and impairment in muscle fiber function, which leads to muscle weakness.